CovidChloroV1, Main, Corpus, bibRecord, 000A03

Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.

Identifieur interne : 000A03 ( Main/Corpus ); précédent : 000A02; suivant : 000A04

Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.

Auteurs : Shih-Chieh Shao ; Edward Chia-Cheng Lai ; Yi-Hua Chen ; Yuk-Ying Chan ; Hui-Yu Chen

Source :

Journal of patient safety [ 1549-8425 ] ; 2021.

RBID : pubmed:33074933

English descriptors

KwdEn :
- Azithromycin (MeSH), COVID-19 (MeSH), Delivery of Health Care (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Pandemics (MeSH), SARS-CoV-2 (MeSH), Taiwan (epidemiology).
MESH :
- chemical , adverse effects : Hydroxychloroquine.
- chemical : Azithromycin.
- geographic , epidemiology : Taiwan.
- COVID-19, Delivery of Health Care, Humans, Pandemics, SARS-CoV-2.

DOI: 10.1097/PTS.0000000000000795
PubMed: 33074933
PubMed Central: PMC7787064

Links to Exploration step

pubmed:33074933

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.</title>
<author><name sortKey="Shao, Shih Chieh" sort="Shao, Shih Chieh" uniqKey="Shao S" first="Shih-Chieh" last="Shao">Shih-Chieh Shao</name>
</author>
<author><name sortKey="Lai, Edward Chia Cheng" sort="Lai, Edward Chia Cheng" uniqKey="Lai E" first="Edward Chia-Cheng" last="Lai">Edward Chia-Cheng Lai</name>
</author>
<author><name sortKey="Chen, Yi Hua" sort="Chen, Yi Hua" uniqKey="Chen Y" first="Yi-Hua" last="Chen">Yi-Hua Chen</name>
</author>
<author><name sortKey="Chan, Yuk Ying" sort="Chan, Yuk Ying" uniqKey="Chan Y" first="Yuk-Ying" last="Chan">Yuk-Ying Chan</name>
</author>
<author><name sortKey="Chen, Hui Yu" sort="Chen, Hui Yu" uniqKey="Chen H" first="Hui-Yu" last="Chen">Hui-Yu Chen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33074933</idno>
<idno type="pmid">33074933</idno>
<idno type="doi">10.1097/PTS.0000000000000795</idno>
<idno type="pmc">PMC7787064</idno>
<idno type="wicri:Area/Main/Corpus">000A03</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A03</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.</title>
<author><name sortKey="Shao, Shih Chieh" sort="Shao, Shih Chieh" uniqKey="Shao S" first="Shih-Chieh" last="Shao">Shih-Chieh Shao</name>
</author>
<author><name sortKey="Lai, Edward Chia Cheng" sort="Lai, Edward Chia Cheng" uniqKey="Lai E" first="Edward Chia-Cheng" last="Lai">Edward Chia-Cheng Lai</name>
</author>
<author><name sortKey="Chen, Yi Hua" sort="Chen, Yi Hua" uniqKey="Chen Y" first="Yi-Hua" last="Chen">Yi-Hua Chen</name>
</author>
<author><name sortKey="Chan, Yuk Ying" sort="Chan, Yuk Ying" uniqKey="Chan Y" first="Yuk-Ying" last="Chan">Yuk-Ying Chan</name>
</author>
<author><name sortKey="Chen, Hui Yu" sort="Chen, Hui Yu" uniqKey="Chen H" first="Hui-Yu" last="Chen">Hui-Yu Chen</name>
</author>
</analytic>
<series><title level="j">Journal of patient safety</title>
<idno type="eISSN">1549-8425</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Delivery of Health Care (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Pandemics (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Taiwan (epidemiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Azithromycin</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Taiwan</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Delivery of Health Care</term>
<term>Humans</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33074933</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1549-8425</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>17</Volume>
<Issue>1</Issue>
<PubDate><Year>2021</Year>
<Month>01</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Journal of patient safety</Title>
<ISOAbbreviation>J Patient Saf</ISOAbbreviation>
</Journal>
<ArticleTitle>Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.</ArticleTitle>
<Pagination><MedlinePgn>e43-e44</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/PTS.0000000000000795</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shao</LastName>
<ForeName>Shih-Chieh</ForeName>
<Initials>SC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lai</LastName>
<ForeName>Edward Chia-Cheng</ForeName>
<Initials>EC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Yi-Hua</ForeName>
<Initials>YH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chan</LastName>
<ForeName>Yuk-Ying</ForeName>
<Initials>YY</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Hui-Yu</ForeName>
<Initials>HY</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Patient Saf</MedlineTA>
<NlmUniqueID>101233393</NlmUniqueID>
<ISSNLinking>1549-8417</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Int J Antimicrob Agents. 2020 Jul;56(1):105949</RefSource>
<PMID Version="1">32205204</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="Y">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>The authors disclose no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>17</Hour>
<Minute>11</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33074933</ArticleId>
<ArticleId IdType="pii">01209203-202101000-00022</ArticleId>
<ArticleId IdType="doi">10.1097/PTS.0000000000000795</ArticleId>
<ArticleId IdType="pmc">PMC7787064</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56:105949.</Citation>
</Reference>
<Reference><Citation>Liu M, Caputi TL, Dredze M, et al. Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med. 2020;180:1116–1118.</Citation>
</Reference>
<Reference><Citation>Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323:1824–1836.</Citation>
</Reference>
<Reference><Citation>Shao SC, Chan YY, Kao Yang YH, et al. The Chang gung research database-a multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28:593–600.</Citation>
</Reference>
<Reference><Citation>Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376:1261–1271.</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A03 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000A03 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33074933
   |texte=   Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33074933" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.

Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki